Skip to main content

Advertisement

Log in

Results of Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases

  • Hepatic and Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Although hepatic artery infusion chemotherapy (HAIC) of floxuridine (FUDR) for colorectal liver metastases (CLM) can produce high response rates, data concerning preoperative HAIC are scarce. The aim of this study was to assess the feasibility and results of liver resection after preoperative HAIC with FUDR.

Methods

Between 1995 and 2004, 239 patients with isolated CLM received HAIC in our institution. Fifty of these patients underwent subsequent curative liver resection (HAIC group). Short- and long-term results of the HAIC group were compared with the outcomes of 50 patients who underwent liver resection for CLM without preoperative chemotherapy.

Results

Postoperative morbidity rate were comparable between the two groups. Overall disease-free survival at 1 and 3 years after hepatectomy were 77.5% and 57.5% in the HAIC group and 62.9% and 37% in the control group (P = .036). Overall survival from diagnosis of CLM at 1, 3, and 5 years were 97%, 59%, and 49% in the HAIC group versus 94%, 48%, and 35% in the control group (P = .097). When patients were stratified according to clinical-risk scoring (CRS) system, patients with more advanced disease at the time of liver resection (CRS ≥3) had a median survival of 41 months in the HAIC group (n = 37) and 35 months in the control group (n = 34) (P = .031).

Conclusions

HAIC of FUDR does not negatively affect the outcome of subsequent liver resection. Preoperative HAIC of FUDR may reduce liver recurrence rate and improve long-term survival in patients with more advanced liver disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1
FIG. 2

Similar content being viewed by others

References

  1. Strangl Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343:1405–10.

    Article  Google Scholar 

  2. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990; 77:1241–6.

    Article  PubMed  CAS  Google Scholar 

  3. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23:2038–48.

    Article  PubMed  CAS  Google Scholar 

  4. Van Cutsem E, Nordlinger B, Rene Adam R, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006 42:2212–21.

    Article  PubMed  Google Scholar 

  5. Sullivan RD, Norcross JW, Watkins E. Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 1964; 270:321–7.

    Article  PubMed  CAS  Google Scholar 

  6. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984; 2:498–504.

    PubMed  CAS  Google Scholar 

  7. Elias D, Lasser P, Rougier P, et al. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995; 180:213–9.

    PubMed  CAS  Google Scholar 

  8. Skitzki JJ, Chang AE. Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials. Surg Oncol 2002; 11:23–35.

    Article  Google Scholar 

  9. Link KH, Pillasch J, Formentini E, et al. Down staging by regional chemotherapy of nonresectable isolated colorectal liver metastases. Eur J Surg Oncol 1999; 25:381–8.

    Article  PubMed  CAS  Google Scholar 

  10. Meric F, Patt YZ, Curley SA, et al. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 2000; 7:490–5.

    Article  PubMed  CAS  Google Scholar 

  11. Clavien PA, Selzner N, Morse M, et al. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery 2002; 131:433–42.

    Article  PubMed  Google Scholar 

  12. Milandri C, Calazolari F, Giampalma E, et al. Combined treatment of inoperable liver metastases from colorectal cancer. Tumori 2003; 89:112–4.

    PubMed  CAS  Google Scholar 

  13. Recommendations for clinical practice: therapeutic management of hepatic metastases from colorectal cancers. Gastroenterol Clin Biol 2003; Special issue II

  14. Aldrighetti L, Arru M, Angeli E, et al. Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy. Hepatogastroenterology 2002; 49:513–7.

    PubMed  Google Scholar 

  15. Venturini M, Angeli E, Salvioni M, et al. Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients. Am J Roentgenol 2004; 182:1417–26.

    Google Scholar 

  16. Aldrighetti L, Pulitanò C, Arru M, et al. “Technological” approach versus clamp crushing technique for hepatic parenchymal transection: a comparative study. J Gastrointest Surg 2006;10:974–9.

    Article  PubMed  Google Scholar 

  17. Pulitanò C, Arru M, Bellio L, et al. A risk score system for predicting perioperative blood transfusion in liver surgery. Br J Surg 2007; 94:860–5.

    Article  PubMed  Google Scholar 

  18. Terminology Committee of the international Hepato-Pancreato-Biliary Association. The IHPBA Brisbane 2000 terminology of liver anatomy and resections. HPB Surg 2000; 2:333–9.

    Google Scholar 

  19. Aldrighetti L, Pulitanò C, Arru M, et al. Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transplant 2006; 12:941–9.

    Article  Google Scholar 

  20. Emori TG, Culver DH, Horan TC, et al. National Nosocomial Infections Surveilance System (NNIS): description of surveilance methods. Am J Infect Control 1991; 19:13–5.

    Google Scholar 

  21. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309–18.

    Article  PubMed  CAS  Google Scholar 

  22. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240:644–57.

    Article  PubMed  Google Scholar 

  23. Giacchetti S, Perpoint B, Zidani R, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2000; 18:136–47.

    PubMed  CAS  Google Scholar 

  24. Fernandez FG, Ritter J, Linehan DC, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pre-treatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005; 200:845–53.

    Article  PubMed  Google Scholar 

  25. Bilchik AJ, Poston G, Curley SA, et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 2005; 23:9073–8.

    Article  PubMed  CAS  Google Scholar 

  26. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243:1–7.

    Article  PubMed  Google Scholar 

  27. Kemeny NE, Steiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992; b69:327–34.

    Article  Google Scholar 

  28. Tanaka K, Shimada H, Kubota K, et al. Effectiveness of prehepatectomy intraarterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. Surgery 2005; 137:156–64.

    Article  PubMed  Google Scholar 

  29. Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006; 24:1395–403.

    Article  PubMed  CAS  Google Scholar 

  30. Kemeny NE, Fong Y, Jarnagin W, et al. A phase I trial of systemic oxaliplatin combinations with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 2005; 23:4888–96.

    Article  PubMed  CAS  Google Scholar 

  31. Kemeny NE, Gönen M, Sullivan D, et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001; 19:2687–95.

    PubMed  CAS  Google Scholar 

  32. Ducreux M, Ychou M, Laplanche A, et al. Combination of hepatic arterial oxaliplatin infusion and intravenous chemotherapy with leucovorin and fluorouracil in colorectal cancer patients with isolated inoperable hepatic metastases. J Clin Oncol 2005; 23:4881–87.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luca Aldrighetti MD, PhD.

Additional information

Part of this article was presented at the International Hepato-Pancreato-Biliary Association, 7th World Congress in Edinburgh, Scotland, September 3–7, 2006.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pulitanò, C., Arru, M., Catena, M. et al. Results of Preoperative Hepatic Arterial Infusion Chemotherapy in Patients Undergoing Liver Resection for Colorectal Liver Metastases. Ann Surg Oncol 15, 1661–1669 (2008). https://doi.org/10.1245/s10434-008-9882-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-9882-5

Key Words

Navigation